BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer

PURPOSE: To test whether the prognostic risk of male sex in papillary thyroid cancer (PTC) is determined by BRAF V600E and can thus be stratified by BRAF status. PATIENTS AND METHODS: We retrospectively investigated the relationship between male sex and clinicopathologic outcomes in PTC, particularl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Wang, Fei, Zhao, Shihua, Shen, Xiaopei, Zhu, Guangwu, Liu, Rengyun, Viola, David, Elisei, Rossella, Puxeddu, Efisio, Fugazzola, Laura, Colombo, Carla, Jarzab, Barbara, Czarniecka, Agnieszka, Lam, Alfred K., Mian, Caterina, Vianello, Federica, Yip, Linwah, Riesco-Eizaguirre, Garcilaso, Santisteban, Pilar, O’Neill, Christine J., Sywak, Mark S., Clifton-Bligh, Roderick, Bendlova, Bela, Sýkorová, Vlasta, Wang, Yangang, Xing, Mingzhao
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2018
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6145834/
https://ncbi.nlm.nih.gov/pubmed/30070937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2018.78.5097
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados